AARD vs MCO · $284.4M cap vs P/E 33, rev $4.26B
Aardvark Therapeutics, Inc. Common Stock (AARD) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
Aardvark Therapeutics, Inc. Common Stock (AARD) is a biotechnology company listed on US.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported AARD revenue for 2025-12-31 was $0. Net income was -$57.6M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AARD currently screens at market cap $284.4M.
Latest reported MCO revenue for 2026-06-30 was $4.26B. Net income was $1.54B. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
AARD currently screens at market cap $284.4M. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the AARD and MCO stock pages for the full models.
Not investment advice.